Old cells, new tricks -- important clue to AML diagnosis and cure discovered

August 01, 2019

Around 22,000 people will be diagnosed this year in the US with acute myeloid leukemia (AML), the second most common type of leukemia diagnosed in adults and children, and the most aggressive of the leukemias. Less than one third of AML patients survive five years beyond diagnosis.

Researchers from Australia's Monash University have discovered a key reason why this disease is so difficult to treat and therefore cure.

The study, led by Associate Professor Ross Dickins from the Australian Centre for Blood Diseases, is published today in the prestigious journal Cell Stem Cell. The paper identifies an important new concept relevant to clinicians involved in the diagnosis and treatment of AML patients.

Acute myeloid leukemia is characterised by an overproduction of immature white blood cells that fail to mature properly. These leukaemia cells crowd the bone marrow, preventing it from making normal blood cells. In turn this causes anaemia, infections, and if untreated, death.

Acute myeloid leukemia remains a significant health problem, with poor outcomes despite chemotherapy and stem cell transplantation.

For decades it has been thought that AML growth is driven by a sub-population of immature cancer cells called 'leukaemia stem cells', which lose their cancerous properties when they mature. Hence there has been growing international interest in developing therapies aimed at forcing immature cancer cells to 'grow up'.

Using genetically engineered mouse models and human AML cells, Associate Professor Dickins and his Monash-led team have found that maturation of AML cells is not unidirectional as originally thought, but can instead be reversible.

The team, which also includes researchers from the Walter and Eliza Hall Institute of Medical Research and several international collaborators, found that even mature AML cells can 'turn back the clock' to become immature again.

This plasticity means that even mature AML cells can make a major contribution to future leukaemia progression and therapy resistance.

The discovery has significant implications for the way that AML is treated, according to Associate Professor Dickins. "The AML field has traditionally accepted a model where leukemia maturation is a one-way street," he said.

"By demonstrating reversible leukaemia maturation, our study raises doubts around therapeutic strategies that specifically target just leukaemia stem cells. It highlights the need to eradicate all tumour cells irrespective of maturation state."

These new findings are important because several new drugs that force leukaemia cells to mature have now entered the clinic. The study by Dickins and colleagues will help clinicians re-shape their thinking to find ways to eradicate mature leukaemia cells along with their immature counterparts.
-end-


Monash University

Related Science Articles from Brightsurf:

75 science societies urge the education department to base Title IX sexual harassment regulations on evidence and science
The American Educational Research Association (AERA) and the American Association for the Advancement of Science (AAAS) today led 75 scientific societies in submitting comments on the US Department of Education's proposed changes to Title IX regulations.

Science/Science Careers' survey ranks top biotech, biopharma, and pharma employers
The Science and Science Careers' 2018 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.

Science in the palm of your hand: How citizen science transforms passive learners
Citizen science projects can engage even children who previously were not interested in science.

Applied science may yield more translational research publications than basic science
While translational research can happen at any stage of the research process, a recent investigation of behavioral and social science research awards granted by the NIH between 2008 and 2014 revealed that applied science yielded a higher volume of translational research publications than basic science, according to a study published May 9, 2018 in the open-access journal PLOS ONE by Xueying Han from the Science and Technology Policy Institute, USA, and colleagues.

Prominent academics, including Salk's Thomas Albright, call for more science in forensic science
Six scientists who recently served on the National Commission on Forensic Science are calling on the scientific community at large to advocate for increased research and financial support of forensic science as well as the introduction of empirical testing requirements to ensure the validity of outcomes.

World Science Forum 2017 Jordan issues Science for Peace Declaration
On behalf of the coordinating organizations responsible for delivering the World Science Forum Jordan, the concluding Science for Peace Declaration issued at the Dead Sea represents a global call for action to science and society to build a future that promises greater equality, security and opportunity for all, and in which science plays an increasingly prominent role as an enabler of fair and sustainable development.

PETA science group promotes animal-free science at society of toxicology conference
The PETA International Science Consortium Ltd. is presenting two posters on animal-free methods for testing inhalation toxicity at the 56th annual Society of Toxicology (SOT) meeting March 12 to 16, 2017, in Baltimore, Maryland.

Citizen Science in the Digital Age: Rhetoric, Science and Public Engagement
James Wynn's timely investigation highlights scientific studies grounded in publicly gathered data and probes the rhetoric these studies employ.

Science/Science Careers' survey ranks top biotech, pharma, and biopharma employers
The Science and Science Careers' 2016 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.

Three natural science professors win TJ Park Science Fellowship
Professor Jung-Min Kee (Department of Chemistry, UNIST), Professor Kyudong Choi (Department of Mathematical Sciences, UNIST), and Professor Kwanpyo Kim (Department of Physics, UNIST) are the recipients of the Cheong-Am (TJ Park) Science Fellowship of the year 2016.

Read More: Science News and Science Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.